| Emily Pembrook, | |
|
2615 Edwards St, Alton, IL 62002-3915 | |
| (618) 462-2331 | |
| (618) 462-2504 |
| Full Name | Emily Pembrook |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 2615 Edwards St, Alton, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003219478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Pembrook, 2615 Edwards St, Alton, IL 62002-3915 Ph: (618) 462-2331 | Emily Pembrook, 2615 Edwards St, Alton, IL 62002-3915 Ph: (618) 462-2331 |
News Archive
Altus Pharmaceuticals Inc. (Nasdaq: ALTU) today announced that on September 15, 2009, the Company received a letter from the Nasdaq Listing Qualifications Department notifying the Company that, for the last 30 consecutive business days, the bid price of the Company's common stock has closed below the minimum $1.00 per share required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The Company's shares will continue to trade on the Nasdaq Capital Market under the symbol "ALTU."
The team at SleepCogni are dedicated to changing the nations' sleep habits and conducted an independent study in October 2015 to give a snapshot view of current sleep behaviour.
Melbourne researchers from the Walter and Eliza Hall Institute have found that inflammatory cells in fat tissue cause the body to become resistant to the effects of insulin – a common precursor to type II diabetes.
GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine].
Claros Diagnostics, a developer of novel point-of-care in vitro diagnostic systems, today announced the CE Mark approval for its rapid quantitative point-of-care diagnostic platform, which can now be used for prostate specific antigen (PSA) testing throughout the European Union. The approved system consists of a small portable analyzer and credit card-sized disposable.
› Verified 6 days ago
Elissha Lenhardt, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Jennifer Tapen, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Joshua Lupardus, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-7160 | |
Lauren Lumpkins, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Erin Loebner, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2615 Edwards St, Alton, IL 62002 Phone: 618-462-2331 Fax: 618-462-2504 | |
Ms. Linda K Moffatt, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 611 W Delmar Ave, Alton, IL 62002 Phone: 618-791-8006 Fax: 618-243-6558 |